Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 4 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2024 Filed Feb 13, 2024 22:58 UTC |
Bengtsson Carl MartinEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 832 | $145.33 | $120,914.56 |
DisclosureSEC source: 0001140361-24-007553 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,746 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/11/2021) Read SEC document |
| February 11, 2024 Filed Feb 13, 2024 22:55 UTC |
Tignor Michael BrentSVP & Chief HR Officer
|
Tax withholdingCommon Stock | 354 | $145.33 | $51,446.82 |
DisclosureSEC source: 0001140361-24-007550 · form4.xml · nonDerivative · entry 1 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,418 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/11/2021) Read SEC document |
| February 11, 2024 Filed Feb 13, 2024 22:02 UTC |
Reid Martin LutherSVP Chief Supply Chain Officer
|
Tax withholdingCommon Stock | 325 | $145.33 | $47,232.25 |
DisclosureSEC source: 0001140361-24-007488 · form4.xml · nonDerivative · entry 1 Reid Martin Luther · CIK 0001906692 · SVP Chief Supply Chain Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,505 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/11/2021) Read SEC document |
| February 11, 2024 Filed Feb 13, 2024 22:00 UTC |
Backus William A.VP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 751 | $145.33 | $109,142.83 |
DisclosureSEC source: 0001140361-24-007482 · form4.xml · nonDerivative · entry 1 Backus William A. · CIK 0001530884 · VP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,914 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/11/2021) Read SEC document |
| February 11, 2024 Filed Feb 13, 2024 21:54 UTC |
van Gunsteren Job LeonardSVP and GM, Specialty Products
|
Tax withholdingCommon Stock | 281 | $145.33 | $40,837.73 |
DisclosureSEC source: 0001140361-24-007478 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,540 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/11/2021) Read SEC document |
| February 11, 2024 Filed Feb 13, 2024 21:48 UTC |
Sestrick Michael RobertSVP & Chief Technology Officer
|
Tax withholdingCommon Stock | 312 | $145.33 | $45,342.96 |
DisclosureSEC source: 0001140361-24-007473 · form4.xml · nonDerivative · entry 1 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,736 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/11/2021) Read SEC document |
| February 11, 2024 Filed Feb 13, 2024 21:08 UTC |
Griffin Jonathan HarrisonSVP & GM, Animal Nutrition
|
Tax withholdingCommon Stock | 220 | $145.33 | $31,972.60 |
DisclosureSEC source: 0001140361-24-007432 · form4.xml · nonDerivative · entry 1 Griffin Jonathan Harrison · CIK 0001907718 · SVP & GM, Animal Nutrition 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,737 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/11/2021) Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:14 UTC |
Sestrick Michael RobertSVP & Chief Technology Officer
|
GrantStock Option · Derivative | 2,000 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007155 · form4.xml · derivative · entry 4 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2034-02-08 F5 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:14 UTC |
Sestrick Michael RobertSVP & Chief Technology Officer
|
Tax withholdingCommon Stock | 1,104 | $143.43 | $158,346.72 |
DisclosureSEC source: 0001140361-24-007155 · form4.xml · nonDerivative · entry 3 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,048 F4 · shares: 1,104 of the 2,069 performance stock units that vested on February 8, 2024 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:14 UTC |
Sestrick Michael RobertSVP & Chief Technology Officer
|
GrantCommon Stock | 2,069 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007155 · form4.xml · nonDerivative · entry 2 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,152 F3 · shares: Represents the vesting of performance stock units (includes 33 dividend equivalent shares) for the 2021-2023 performance period. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:14 UTC |
Sestrick Michael RobertSVP & Chief Technology Officer
|
GrantCommon Stock | 610 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007155 · form4.xml · nonDerivative · entry 1 Sestrick Michael Robert · CIK 0001906436 · SVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,083 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:08 UTC |
Rigaud OlivierDirector
|
GrantStock Option · Derivative | 1,730 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007152 · form4.xml · derivative · entry 2 Rigaud Olivier · CIK 0001988789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,730 Underlying: Common Stock · 1,730 shares Expires 2034-02-08 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3 Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:08 UTC |
Rigaud OlivierDirector
|
GrantCommon Stock | 540 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007152 · form4.xml · nonDerivative · entry 1 Rigaud Olivier · CIK 0001988789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 540 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:08 UTC |
VICENTE MONICADirector
|
GrantStock Option · Derivative | 1,730 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007151 · form4.xml · derivative · entry 2 VICENTE MONICA · CIK 0001917126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,730 Underlying: Common Stock · 1,730 shares Expires 2034-02-08 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3 Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:08 UTC |
VICENTE MONICADirector
|
GrantCommon Stock | 540 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007151 · form4.xml · nonDerivative · entry 1 VICENTE MONICA · CIK 0001917126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 540 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:05 UTC |
Boned FredericSVP/GM, Human Nutri. & Health
|
GrantStock Option · Derivative | 4,500 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007148 · form4.xml · derivative · entry 2 Boned Frederic · CIK 0001953220 · SVP/GM, Human Nutri. & Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,500 Underlying: Common Stock · 4,500 shares Expires 2034-02-08 F3 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:05 UTC |
Boned FredericSVP/GM, Human Nutri. & Health
|
GrantCommon Stock | 1,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007148 · form4.xml · nonDerivative · entry 1 Boned Frederic · CIK 0001953220 · SVP/GM, Human Nutri. & Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,322 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:04 UTC |
van Gunsteren Job LeonardSVP and GM, Specialty Products
|
GrantStock Option · Derivative | 1,500 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007146 · form4.xml · derivative · entry 4 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2034-02-08 F4 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:04 UTC |
van Gunsteren Job LeonardSVP and GM, Specialty Products
|
Tax withholdingCommon Stock | 957 | $143.43 | $137,262.51 |
DisclosureSEC source: 0001140361-24-007146 · form4.xml · nonDerivative · entry 3 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,821 F3 · shares: 957 of the 1,704 performance stock units that vested on February 8, 2024 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:04 UTC |
van Gunsteren Job LeonardSVP and GM, Specialty Products
|
GrantCommon Stock | 1,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007146 · form4.xml · nonDerivative · entry 2 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,778 F2 · shares: Represents the vesting of performance stock units (includes 27 dividend equivalent shares) for the 2021-2023 performance period. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:04 UTC |
van Gunsteren Job LeonardSVP and GM, Specialty Products
|
GrantCommon Stock | 470 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007146 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,074 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:01 UTC |
Reid Martin LutherSVP Chief Supply Chain Officer
|
GrantStock Option · Derivative | 3,400 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007142 · form4.xml · derivative · entry 5 Reid Martin Luther · CIK 0001906692 · SVP Chief Supply Chain Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,400 Underlying: Common Stock · 3,400 shares Expires 2034-02-08 F6 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:01 UTC |
Reid Martin LutherSVP Chief Supply Chain Officer
|
Tax withholdingCommon Stock | 582 | $143.43 | $83,476.26 |
DisclosureSEC source: 0001140361-24-007142 · form4.xml · nonDerivative · entry 4 Reid Martin Luther · CIK 0001906692 · SVP Chief Supply Chain Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,830 F5 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/8/2021) Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:01 UTC |
Reid Martin LutherSVP Chief Supply Chain Officer
|
Tax withholdingCommon Stock | 1,106 | $143.43 | $158,633.58 |
DisclosureSEC source: 0001140361-24-007142 · form4.xml · nonDerivative · entry 3 Reid Martin Luther · CIK 0001906692 · SVP Chief Supply Chain Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,412 F4 · shares: 1,106 of the 3,063 performance stock units that vested on February 8, 2024 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:01 UTC |
Reid Martin LutherSVP Chief Supply Chain Officer
|
GrantCommon Stock | 3,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007142 · form4.xml · nonDerivative · entry 2 Reid Martin Luther · CIK 0001906692 · SVP Chief Supply Chain Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,518 F3 · shares: Represents the vesting of performance stock units (includes 47 dividend equivalent shares) for the 2021-2023 performance period. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:01 UTC |
Reid Martin LutherSVP Chief Supply Chain Officer
|
GrantCommon Stock | 1,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007142 · form4.xml · nonDerivative · entry 1 Reid Martin Luther · CIK 0001906692 · SVP Chief Supply Chain Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,455 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:01 UTC |
Tignor Michael BrentSVP & Chief HR Officer
|
GrantStock Option · Derivative | 2,900 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007141 · form4.xml · derivative · entry 4 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,900 Underlying: Common Stock · 2,900 shares Expires 2034-02-08 F5 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:01 UTC |
Tignor Michael BrentSVP & Chief HR Officer
|
Tax withholdingCommon Stock | 1,244 | $143.43 | $178,426.92 |
DisclosureSEC source: 0001140361-24-007141 · form4.xml · nonDerivative · entry 3 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,772 F4 · shares: 1,244 of the 2,104 performance stock units that vested on February 8, 2024 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:01 UTC |
Tignor Michael BrentSVP & Chief HR Officer
|
GrantCommon Stock | 2,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007141 · form4.xml · nonDerivative · entry 2 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,016 F3 · shares: Represents the vesting of performance stock units (includes 33 dividend equivalent shares) for the 2021-2023 performance period. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:01 UTC |
Tignor Michael BrentSVP & Chief HR Officer
|
GrantCommon Stock | 900 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007141 · form4.xml · nonDerivative · entry 1 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,912 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:50 UTC |
Miyata HatsukiEVP, Gen. Counsel & Secretary
|
GrantStock Option · Derivative | 3,800 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007134 · form4.xml · derivative · entry 2 Miyata Hatsuki · CIK 0001939613 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,800 Underlying: Common Stock · 3,800 shares Expires 2034-02-08 F3 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:50 UTC |
Miyata HatsukiEVP, Gen. Counsel & Secretary
|
GrantCommon Stock | 1,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007134 · form4.xml · nonDerivative · entry 1 Miyata Hatsuki · CIK 0001939613 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,658 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:49 UTC |
Knutson Daniel EDirector
|
GrantStock Option · Derivative | 1,730 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007131 · form4.xml · derivative · entry 2 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,730 Underlying: Common Stock · 1,730 shares Expires 2034-02-08 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3 Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:49 UTC |
Knutson Daniel EDirector
|
GrantCommon Stock | 540 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007131 · form4.xml · nonDerivative · entry 1 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,049 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:46 UTC |
Lee Joyce J.Director
|
GrantStock Option · Derivative | 1,730 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007128 · form4.xml · derivative · entry 2 Lee Joyce J. · CIK 0001567830 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,730 Underlying: Common Stock · 1,730 shares Expires 2034-02-08 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3 Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:46 UTC |
Lee Joyce J.Director
|
GrantCommon Stock | 540 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007128 · form4.xml · nonDerivative · entry 1 Lee Joyce J. · CIK 0001567830 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,776 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:42 UTC |
Griffin Jonathan HarrisonSVP & GM, Animal Nutrition
|
GrantStock Option · Derivative | 2,400 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007122 · form4.xml · derivative · entry 4 Griffin Jonathan Harrison · CIK 0001907718 · SVP & GM, Animal Nutrition 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,400 Underlying: Common Stock · 2,400 shares Expires 2034-02-08 F5 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:42 UTC |
Griffin Jonathan HarrisonSVP & GM, Animal Nutrition
|
Tax withholdingCommon Stock | 793 | $143.43 | $113,739.99 |
DisclosureSEC source: 0001140361-24-007122 · form4.xml · nonDerivative · entry 3 Griffin Jonathan Harrison · CIK 0001907718 · SVP & GM, Animal Nutrition 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,957 F4 · shares: 793 of the 2,390 performance stock units that vested on February 8, 2024 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:42 UTC |
Griffin Jonathan HarrisonSVP & GM, Animal Nutrition
|
GrantCommon Stock | 2,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007122 · form4.xml · nonDerivative · entry 2 Griffin Jonathan Harrison · CIK 0001907718 · SVP & GM, Animal Nutrition 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,750 F3 · shares: Represents the vesting of performance stock units (includes 36 dividend equivalent shares) for the 2021-2023 performance period. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:42 UTC |
Griffin Jonathan HarrisonSVP & GM, Animal Nutrition
|
GrantCommon Stock | 720 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007122 · form4.xml · nonDerivative · entry 1 Griffin Jonathan Harrison · CIK 0001907718 · SVP & GM, Animal Nutrition 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,360 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:42 UTC |
Harris Theodore LDirector · Chairman, President & CEO
|
GrantStock Option · Derivative | 21,500 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007121 · form4.xml · derivative · entry 4 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,500 Underlying: Common Stock · 21,500 shares Expires 2034-02-08 F5 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:42 UTC |
Harris Theodore LDirector · Chairman, President & CEO
|
Tax withholdingCommon Stock | 11,768 | $143.43 | $1,687,884.24 |
DisclosureSEC source: 0001140361-24-007121 · form4.xml · nonDerivative · entry 3 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,543 F4 · shares: 11,768 of the 20,639 performance stock units that vested on February 8, 2024 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:42 UTC |
Harris Theodore LDirector · Chairman, President & CEO
|
GrantCommon Stock | 20,639 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007121 · form4.xml · nonDerivative · entry 2 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,311 F3 · shares: Represents the vesting of performance stock units (includes 316 dividend equivalent shares) for the 2021-2023 performance period. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:42 UTC |
Harris Theodore LDirector · Chairman, President & CEO
|
GrantCommon Stock | 6,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007121 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,672 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:37 UTC |
Fish Kathleen BDirector
|
GrantStock Option · Derivative | 1,730 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007118 · form4.xml · derivative · entry 2 Fish Kathleen B · CIK 0001598156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,730 Underlying: Common Stock · 1,730 shares Expires 2034-02-08 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3 Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:37 UTC |
Fish Kathleen BDirector
|
GrantCommon Stock | 540 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007118 · form4.xml · nonDerivative · entry 1 Fish Kathleen B · CIK 0001598156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,579 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:25 UTC |
Bengtsson Carl MartinEVP & Chief Financial Officer
|
GrantStock Option · Derivative | 6,800 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007111 · form4.xml · derivative · entry 4 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,800 Underlying: Common Stock · 6,800 shares Expires 2034-02-08 F5 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:25 UTC |
Bengtsson Carl MartinEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 2,868 | $143.43 | $411,357.24 |
DisclosureSEC source: 0001140361-24-007111 · form4.xml · nonDerivative · entry 3 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,578 F4 · shares: 2,868 of the 4,965 performance stock units that vested on February 8, 2024 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:25 UTC |
Bengtsson Carl MartinEVP & Chief Financial Officer
|
GrantCommon Stock | 4,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007111 · form4.xml · nonDerivative · entry 2 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,446 F3 · shares: Represents the vesting of performance stock units (includes 75 dividend equivalent shares) for the 2021-2023 performance period. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:25 UTC |
Bengtsson Carl MartinEVP & Chief Financial Officer
|
GrantCommon Stock | 2,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007111 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,481 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.